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Reactive oxygen speciesStat3 is an important transcription factor that regulates both proinﬂammatory and anti-apoptotic pathways
in the heart. This study examined the mechanisms of activation of Stat3 in human endothelial cells following
hypoxia/reoxygenation (H/R). By expression of constitutively active Rac1 mutant protein, and by RNA
silencing of Rac1, we found that Stat3 Y705 and S727 phosphorylation following H/R is dependent on Rac1.
Reactive oxygen species produced during H/R, and direct physical association with Rac1 both contribute to
Stat3 activation. Stat3 forms a multiprotein complex with Rac1 and PKC in an H/R-dependent manner,
which at least in part, appears to regulate Stat3 S727 phosphorylation. Selective inhibition of PKC with cal-
phostin C produces a marked suppression of Stat3 S727 phosphorylation. The association of Stat3 with
Rac1 occurs predominantly at the cell membrane, but also inside the nucleus, and occurs through the binding
of the coiled-coil domain of Stat3 to the 54 NH2-terminal residues of Rac1. Transfection with a peptide com-
prising the NH2-terminal 17 amino acid residues of Rac1 inhibits Stat3 S727 phosphorylation after H/R. Thus,
Stat3 is activated in endothelial cells by H/R through Rac1-dependent signaling pathways resulting in phys-
ical association between Rac1 and Stat3 and the formation of a novel multiprotein complex with PKC.
© 2012 Elsevier B.V. All rights reserved.1. Introduction
Ischemia–reperfusion (I/R) causes activation of a number of tran-
scription factors which regulate genes involved in inﬂammation, apo-
ptosis, and cellular growth and repair [1–3]. Signal transducers and
activators of transcription (Stat) proteins have received attention as
important gene regulators following I/R [4–6]. Upon activation, Stats
form homo- or heterodimers, translocate to the nucleus, and activate
transcription by binding to target genes [7]. Within the family of
Stats, Stat3 upregulates a number of pro-inﬂammatory genes in endo-
thelial cells, including cytokines, chemokines, and adhesionmolecules
[5,6,8,9]. Stat3 has been shown to mediate protection of the heart and
other organs against I/R injury [10], and is also essential for the cardi-
oprotection resulting from both pre- and post-ischemic conditioning
[11–13]. Stat3 is therefore an important signalingmolecule in the con-
text of I/R, and an understanding of themechanisms involved in its ac-
tivation is of considerable interest.
Dimerization and DNA binding of Stat3 require phosphorylation of
its Y705 residue, but full transcriptional activity is believed to necessi-
tate phosphorylation of both Y705 and S727 residues [14]. We recentlyt., Baltimore, MD 21287-5500,
.
rights reserved.found that phosphorylation of S727was followed by binding of Stat3 to
the transcriptional regulator speciﬁcity protein 1 (Sp1), and that this
transcriptional complex enhanced the expression of the inﬂammatory
molecule intercellular adhesion molecule-1 (ICAM-1) in endothelial
cells following I/R [5]. Interestingly, other downstream actions of acti-
vated Stat3 have been described which result in anti-inﬂammatory
effects, mediated through induction of heme oxygenase-1 [15], and
Stat3 has also been reported to mediate expression of anti-apoptotic
genes in the heart [8,16]. Activation of Stat3 is found in human cancers,
and the guanosine triphosphatase Rac1, a subunit of the NADPH-
oxidase, is thought to play a role [17]. Stat3 is also activated in several
cell types following exposure to growth factors or cytokines, presum-
ably through receptor-related tyrosine phosphorylation, or tyrosine
phosphorylation by Janus kinases (JAKs) [18,19]. Rac1 binds to Stat3
in COS-1 and smooth muscle cells treated with growth factors, and ap-
pears to regulate the phosphorylation of tyrosine and serine residues
[20,21]. However, the domains involved in this important protein–
protein interaction have not been determined.
Reactive oxygen species (ROS) have been implicated as a key factor
in activation of the JAK–Stat pathway [22,23]. ROS are generated in
large quantities during I/R or hypoxia/reoxygenation (H/R) [24], and
are also produced in response to cytokines and growth factors [22,25].
The NADPH-oxidase is a major source of ROS in endothelial cells as
well as in other cell types [26,27], and its activity is well known to be
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tion could occur either by physical binding of Rac1 with Stat proteins
to facilitate their targeting to speciﬁc protein kinases [20], or by Rac1-
dependent ROS production, which could indirectly activate different
protein kinases, resulting in downstream activation of Stat proteins
[31].
Our study is the ﬁrst to examine the pathways involved in Stat3
activation following hypoxia/reoxygenation. We demonstrate that
Rac1 is essential for Stat3 activation in this context, and that both
Rac1-induced ROS generation and physical binding between Rac1
and Stat3 are involved. Further, we show that Stat3 activation after
H/R is dependent on PKC, which forms a novel multiprotein complex
with Rac1 and Stat3.
2. Materials and methods
2.1. cDNA cloning and site-directed mutagenesis
Full-length hStat3α and human wild-type (wt) Rac1 (hRac1-wt)
were ampliﬁed by RT-PCR from total RNA isolated from human umbili-
cal vein endothelial cells (HUVECs), and cloned using standardmethods.
Expression constructs of constitutively active (CA) Rac1 (Rac1 G12V)
and deletion constructs were made using standard methods. Full-
length mStat3α and hStat3α were subcloned and Stat3 deletion
constructs were made and ampliﬁed using custom designed primers.
Accuracy of the reading frame and authenticity of deletions were veri-
ﬁed by Western blotting and/or DNA sequencing.
2.2. Cell culture and exposure to hypoxia/reoxygenation
HUVECswere cultured in EGM-2 growthmedium (Cambrex). COS-7
and 293 cells were grown in DMEM supplemented with 10% heat-
inactivated FBS. Cells were incubated for 2 h at 37 °C under normoxic
conditions or in ischemia buffer [32] under a hypoxic gas mixture as
described [5], and reoxygenated in fresh modiﬁed Esumi buffer [20] at
37 °C.
2.3. Adenoviral infection, and transient and stable transfection
Construction of adenoviruses expressing β-galactosidase or CA Rac1
has been described [33]. The viruses were ampliﬁed in HEK 293 cells,
followed by puriﬁcation and measurement of titers. HUVECs or COS-7
cells were infected for 6 h with 50 ICU/cell of viral particles expressing
CA Rac1 or β-gal (control virus) and used 36–48 h later. HUVECs were
transfected with 20 pmol/ml control siRNA, or siRNA speciﬁc for Rac1
[34] or with other constructs and harvested 48–72 h later. Stable trans-
formants were selected with G418 using standard protocols.
2.4. Construction of Rac1 NH2-terminal peptide and expression vectors,
and transfection of 293 cells and HUVECs
Peptides were constructed representing the 54 NH2-terminal amino
acids of Rac1 to block the interaction between Rac1 and Stat3. cDNA
fragments corresponding to two peptides (residues 1–17 (Rac1–17)
and 23–54 (Rac1–54)) were transcribed and ampliﬁed by R-T PCR and
cloned. 293 cells were grown to 70% conﬂuence in 6-well plates, and
0.6 μg DNA construct was transfected into each well. After 48 h, the
cells were exposed to hypoxia for 2 h and reoxygenation for 30 min.
The cells were then lysed and harvested for Western blotting.
In other experiments, FITC-labeled Rac1–17 was synthesized by
ChemPep Inc. (Miami, FL) and 2 μg of peptide or control IgGwas trans-
fected directly into cultured HUVECs. After 4 h, the cells were exposed
to hypoxia for 2 h and reoxygenation for 15 or 30 min. The cells were
observed by ﬂuorescent microscopy to document successful transfec-
tion and harvested for Western blotting.2.5. Immunoprecipitation and immunoblotting
Cells were exposed to normoxia or H/R and lysed in IP buffer. Im-
munoprecipitation and immunoblotting were done as described pre-
viously [35].
2.6. Yeast two-hybrid interaction
Interaction between full-length Rac1 and Stat3 and their segments
was examined using theMATCHMAKER two-hybrid system II (Clontech)
as described previously [35,36].
2.7. In vitro binding assays
Recombinant GST/Rac1 proteins were expressed and afﬁnity-
puriﬁed by coupling to glutathione-Sepharose beads as described
[35,36]. 35S-labeled Stat3α proteins were translated in vitro. Equal
amounts of Stat3 proteins/polypeptides were incubated with 10 μg
of GST/Rac1-fusion proteins, washed, fractionated by SDS-PAGE and
detected by ﬂuorography.
2.8. Immunoﬂuorescence staining and confocal microscopy
HUVECs were grown on poly-L-lysine coated coverslips and exposed
to hypoxia for 2 h and reoxygenation for 15, 30, or 60 min. Cells were
ﬁxed with 4% paraformaldehyde for 10 min, and permeabilized with
methanol in−20 °C for 10 min (Fig. 5) or with 0.5% Triton X-100 in TBS
at room temperature for 15 min (Fig. 6). Single or dual immunoﬂuores-
cence staining was performed using 1:100 dilution of rabbit anti-human
p-S727 Stat3 or Stat3 polyclonal antibodies (Cell Signaling Technology,
Danvers, MA), goat anti-human PKCζ polyclonal antibody (Santa Cruz
Biotechnology, Inc., Santa Cruz, CA) and/or mouse anti-Rac1 mAb (Up-
state) as described previously [35,36]. Secondary antibodies included
Northern Light donkey anti-rabbit-IgG-NL637 and anti-goat IgG-NL493
(R&D Systems, Minneapolis, MN). Confocal microscopy was performed
using a Carl Zeiss 510 confocal microscope.
2.9. PKCζ knockdown by siRNA
PKCζ siRNA, control siRNA and goat anti-human PKCζ polyclonal
antibody were purchased from Santa Cruz Biotechnology, Inc. (Santa
Cruz, CA). HUVECs were cultured in 6 well plates to 80% conﬂuence.
50 pmol/ml siRNA or control siRNA was transfected into the cells
using Effectene Transfection Reagent (QIAGEN, Inc, Valencia, CA).
48 h later, the cells were exposed to hypoxia for 2 h and reoxygena-
tion for 30 min, and then lysed and analyzed by Western blotting.
2.10. Densitometry and statistical analysis
Chemiluminograms were analyzed by densitometry using the
ImageJ software (http://rsbweb.nih.gov/ij/). Band densities were normal-
ized to an internal control for each lane and expressed as a percent of con-
trol conditions (deﬁned as 100%). Band densities were then averaged for 3
independent experiments and differences between laneswere analyzed by
paired t-test. P values of≤0.05 were considered statistically signiﬁcant.
3. Results
3.1. Stat3 phosphorylation following hypoxia–reoxygenation is Rac1
dependent
To examine if Stat3 activation following H/R is regulated through
Rac1 activity, we analyzed the effect of exogenously expressed CA
Rac1 on Stat3 phosphorylation in HUVECs. Infection of cells with ade-
noviruses expressing β-gal (control virus) had no effect on phosphor-
ylation status of Stat3 Y705 or S727 compared to uninfected cells in
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an increased level of phosphorylation of both residues in β-gal expres-
sing cells (Fig. 1A,C). Expression of CA Rac1 in these cells during nor-
moxia resulted in increased phosphorylation of Stat3 Y705 and S727,
with a further increase in phosphorylation upon exposure to H/R,
without a change in expression of Stat3 (Fig. 1A,C). Western blots of
cell lysates conﬁrmed that CA Rac1 adenoviruses increased the intra-
cellular level of Rac1 protein (Fig. 1B). Our results are consistent
with an earlier report of Rac1-dependent Stat3 activation in EGF-
induced COS-1 cells [20]. However, in another study, expression of
CA Rac1 was reported not to affect Stat3 Y705 phosphorylation in
IL-6-induced HepG2 cells [37].
To further examinewhether Rac1 regulates Stat3 phosphorylation,
we analyzed the effect of knockdown of Rac1 with siRNA on Stat3
phosphorylation (Fig. 2A,B). siRac1 resulted in a partial inhibition of
Stat3 Y705 phosphorylation, but a more marked inhibition of Stat3
S727 phosphorylation, both during normoxia and following H/R.3.2. Stat3 activation following H/R is mediated through production of
ROS
To determine if Stat3 activation ismediated directly by ROS generated
upon H/R, we examined the effect of N-acetyl cysteine (NAC), an
antioxidant, on the H/R-induced phosphorylation of Stat3 (Fig. 3A,B).
Pretreatment of cellswith 400 μMNAC for 2 h resulted in an approximate
50% suppression (pb0.01) of H/R-induced phosphorylation of both Stat3
Y705 and S727 without affecting expression of Stat3. NAC suppressed
H/R induced Stat3 phosphorylation at both Y705 and S727 to a similar
extent following infection with adenoviruses carrying CA Rac1
(Fig. 3B). Inhibition of Stat3 phosphorylation by NAC also occurred dur-
ing normoxia but was quantitatively somewhat less. These results sug-
gest that reactive oxygen species generated during H/R, at least in part,
are involved in Stat3 activation.Fig. 1. Stat3 phosphorylation following hypoxia–reoxygenation is increased by CA Rac1
in HUVECs. (A) CA Rac1 increases Y705 and S727 Stat3 phosphorylation, both in nor-
moxia (N) and after H/R. (B) Expression of CA Rac1 after 48 h infection. (C) Densitom-
etry of Western blots in (A). Values are mean±SEM, expressed relative to the blot for
Ad β-gal under normoxic conditions and averaged for 3 independent experiments.
**pb0.01 vs N for Ad β-gal or vs N for Ad CA Rac1 as indicated.3.3. Association of Stat3with Rac1 and PKC, and Stat3 S727 phosphorylation
are augmented following exposure to hypoxia–reoxygenation
To determine if Rac1 activates Stat3 following H/R by directly asso-
ciating with Stat3, we immunoprecipitated endogenous Stat3 from
HUVEC lysates and looked for Rac1 coprecipitation. We found sugges-
tive evidence for increased association betweenRac1 and Stat3 following
H/R, but we were unable to obtain an adequate amount of Stat3 protein
from HUVECs for a deﬁnitive result. We therefore performed additional
experiments in COS-7 cells stably expressing mStat3α. In these cells,
we found an association of Stat3 with Rac1 under normoxic conditions
(Fig. 4A, lane 3), which increased substantially (pb0.01) following H/R
(Fig. 4A, lane 2; Fig. 4D) and even further following H/R with exogenous
expression of CA Rac1 (Fig. 4A, lane 4; Fig. 4D).
To identify tyrosine- or serine/threonine-kinases that might associ-
ate with Stat3 and catalyze phosphorylation of its Y705 and S727 moi-
eties, we examined co-precipitation of candidate protein kinases with
Stat3. Since different isoforms of PKC are activated during H/R
[38–40], we looked at PKC, and found that it did in fact co-precipitate
with Stat3 along with Rac1. The amount of PKC in the complex in-
creased signiﬁcantly (pb0.01) with exposure of cells to H/R (Fig. 4D;
compare lanes 3 and 2 in Fig. 4A) and increased further upon expression
of CA Rac1 and exposure to H/R (Fig. 4D; compare lanes 3 and 4 in
Fig. 4A). The anti-PKC Ab used in these experiments detects all PKC
family members (sc-10800, Santa Cruz Biotech). Further analysis of
the Stat3 immunoprecipitates revealed that PKCζ co-precipitates with
Stat3, in an H/R-dependent manner (Fig. 4A).
In complementary experiments, we immunoprecipitated PKC
(using sc-10800, Santa Cruz Biotech, raised against a C-terminal seg-
ment of human PKCα) from COS-7 cells stably expressing mStat3α
and examined the immunoprecipitates for co-precipitation of Stat3.
Stat3 and Rac1 co-precipitated with PKC in an H/R-dependent man-
ner (Fig. 4B, compare normoxia in lane 3 with H/R in lane 2; quanti-
tatively the increase was about 4-fold for Rac1, but could not be
calculated for Stat3 because of the absence of a Stat3 band in nor-
moxia, Fig. 4E). Their association with PKC increased with exogenous
expression of CA Rac1 (compare lane 2 with lane 4, Fig. 4B). Quanti-
tatively, association of Rac1 with PKC increased by about 9-fold fol-
lowing H/R and expression of CA Rac1 (Fig. 4E). In addition, there
was a small further increase in Stat3 association with PKC following
expression of CA Rac1 and H/R compared to H/R alone (Fig. 4B, lane
2 vs lane 4). Further analysis of the Stat3/PKC immunoprecipitates
suggested that S727 phosphorylation of Stat3 increased following
H/R and that the increase was even greater with exogenous CA Rac1
expression (Fig. 4B). This ﬁnding is consistent with PKC playing a
role in Stat3 S727 phosphorylation, and in further support of this
idea, pretreatment of HUVECswith a highly speciﬁc PKC inhibitor, Cal-
phostin C (1 μM) [41], signiﬁcantly (pb0.01) suppressed Stat3 S727
phosphorylation in normoxia and following H/R in both control (Ad
β-gal infected) and Ad CA Rac1-infected cells (Fig. 4C,F). Pretreatment
of cells with another speciﬁc PKC inhibitor, chelerythrine [42], also
suppressed H/R-induced S727 phosphorylation (not shown). These
results suggest that association of Stat3 with Rac1 and PKC may be,
at least in part, a novel mechanism of Stat3 activation following H/R.
3.4. PKCζ knockdown by siRNA inhibits Stat3 phosphorylation following
hypoxia–reoxygenation
To determine if PKCζ participates in the phosphorylation of Stat3,
we transfected HUVECs with PKCζ siRNA or negative control siRNA,
and 48 h later subjected the cells to hypoxia for 2 h and reoxygenation
for 30 min or a corresponding period of normoxia (Fig. 5A,B). Knock-
down of PKCζwas associatedwith a reduction in S727-Stat3 phosphor-
ylation, both during normoxia, and following hypoxia–reoxygenation.
The results are consistent with the immunoprecipitation experiments
(Fig. 4) and support a role for PKCζ in Stat3 S727 phosphorylation.
Fig. 2. (A) Stat3 phosphorylation following hypoxia–reoxygenation is inhibited by siRNA for Rac1. (B) Densitometry of 3 blots, with data normalized for Stat3 (loading control).
Values represent mean±SEM. **pb0.01 for indicated comparison or comparison to Control siRNA during N.
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hypoxia–reoxygenation
To further examine the association between Stat3 and PKCζ, and
determine the subcellular location of their interaction, we examined
if Stat3 and PKCζ colocalize by immunoﬂuorescent staining and confo-
cal microscopy (Fig. 5C,D). Following hypoxia and 15 min reoxygena-
tion (Fig. 5C), Stat3 (red) was localized mainly in the cytoplasm, with
someweaker Stat3 staining in the nucleus, while PKCζ (green)was lo-
calized exclusively in the cytoplasm. Colocalization (yellow) occurred
in the cytoplasm but not the nucleus. After 60 min reoxygenation
there was still no nuclear colocalization of Stat3 and PKCζ (not
shown). However, we also tracked the location of pS727-Stat3 and in-
terestingly found that after 60 min reoxygenation (Fig. 5D), pS727-
Stat3 was located in both the cytoplasm and nucleus, while PKCζ
remained nearly completely cytoplasmic (no colocalization seen in
either the cytoplasm or nucleus). These results are consistent with cy-
toplasmic phosphorylation of Stat3 by PKCζ early after reperfusion
(Fig. 5C), with subsequent dissociation of phosphorylated Stat3 from
PKCζ and passage of activated Stat3 into the nucleus (Fig. 5D).Fig. 3. (A) N-acetyl cysteine (NAC) reduces phosphorylation of both Y705 and S727 Stat3 in H
normalized for Stat3 (loading control). Values represent mean±SEM. **p≤0.01 for indicat3.6. Stat3 and activated Rac1 colocalize at the cell membrane and inside
the nucleus following exposure to hypoxia–reoxygenation
To further examine the association between Stat3 and Rac1, we
looked for subcellular colocalization of Rac1 and Stat3 (Fig. 6). Since
activated Stat3 translocates to the nucleus, cells were ﬁxed within
5 min of reoxygenation to minimize the effects of translocation and
determine the intracellular locales of Stat3/Rac1 association. Follow-
ing exposure of HUVECs infected with Ad β-gal to hypoxia and 5 min
reoxygenation, Stat3 was found mainly in the nucleus (red), with
weak staining also in the cytoplasm. In these same cells, Rac1 was
also localized primarily in the nucleus, with weaker staining at the
cell membrane and diffusely in the cytoplasm (green, A1). However,
in cells infected with Ad CA Rac1, prominent staining for Rac1 and
Stat3 was observed at the cell membrane (arrow), nuclear membrane
(arrowhead), inside the nucleus, and to a certain extent in the peri-
nuclear region (B, B1). The merged image (B2) showed colocalization
of Stat3 and Rac1 (yellow) at the cell membrane (indicated by arrow),
nuclear membrane (indicated by arrowhead) and inside the nucleus,
upon exposure of cells to H/R. There was also weak colocalization inUVECs, both in normoxia (N), and following H/R. (B) Densitometry of 3 blots, with data
ed comparison.
Fig. 4. Stat3 activation following H/R is regulated by association of Stat3 with Rac1 and PKC. (A) In COS-7 cells stably expressing Stat3, the amount of Rac1 coprecipitating with Stat3
increased during H/R (lane 3 vs 2) and following infection with Ad CA Rac1 (lane 4), and the immunoprecipitate also contained PKC and its ζ isoform. (B) In COS-7/Stat3 stable cells,
the amounts of Stat3, p-S727 Stat3, and Rac1 co-precipitating with PKC increased during H/R and following infection with Ad CA Rac1. (C) In HUVECs, pretreatment with the speciﬁc
PKC inhibitor Calphostin C (1 μM) reduced S727 Stat3 phosphorylation during normoxia and H/R, with or without Ad CA Rac1 infection. (D,E,F) Densitometry of (A), (B) and (C),
respectively, on 3 blots for each panel. Normalization was for the amount of Stat3 in (D), PKC in (E), and for Stat3 (loading control) in (F). Values are mean±SEM. **p≤0.01 for
indicated comparison, or comparison to N.
1001S.N. Mattagajasingh et al. / Biochimica et Biophysica Acta 1823 (2012) 997–1006the cytoplasm. The prominent membrane localization of Stat3 and its
colocalization with CA Rac1 at the cell membrane observed upon H/R
was not apparent in cells kept in normoxia (C, C2). The increased colo-
calization of CA Rac1 and Stat3 following H/R is consistent with the
increased association between Rac1 and Stat3 we observed in immu-
noprecipitation experiments (Fig. 4).3.7. Stat3 and Rac1 interact through the amino acid residues within the
coiled-coil domain of Stat3 and the NH2-terminal 54 amino acids of Rac1
To determine if Stat3 and Rac1 interact directly, and to map their
interacting domains, we performed yeast two-hybrid assays. As
shown in Fig. 7, Stat3 interacted with full-length activated Rac1, and
with its AA segments 1–54, 1–122, 1–142, or 1–180, but not with AA
segments 40–192, 101–192 or 141–192 (Fig. 7A). Similarly, activated
Rac1 interacted with the full-length hStat3α, and its AA segments
107–770 or 131–377, but not with AA segments 1–130, 321–770 or
378–770 (Fig. 7B). Expression of Gal4-BD fusion proteins of full-
length CA Rac1 or any of its segments alone, Gal4-AD fusion proteins
of full-length Stat3α or its segments alone, or in combination with
their complementary Gal4 domain did not activate expression of the
reporter genes. These results indicate that the amino acids that sustain
Rac1 and Stat3α interaction reside within amino acids 1–54 of Rac1
and the coiled-coiled domain (AA 131–320) of Stat3α.3.8. Stat3 binds to Rac1 in vitro
To conﬁrm direct interaction between Stat3 and Rac1, we per-
formed in vitro binding assays. As shown in Fig. 8A, CA Rac1 and its dif-
ferent segments were expressed as GST fusion-proteins in bacteria
and puriﬁed. In vitro binding was performed between GST/Rac1 and
35S-labeled in vitro translated Stat3. Stat3 was found to bind to GST-
fusion proteins of CA Rac1, its segments containing AAs 1–54, 1–122,
1–142 and 1–180, but not to AAs 50–192, or GST alone (Fig. 8B).
Stat3 segments comprising AAs 1–320 and 131–377 bound to GST/
CA-Rac1, but the segment containing AAs 321–770 failed to bind
(Fig. 8C), conﬁrming an interaction between the coiled-coil domain
of Stat3α and NH2-terminal 54 AAs of Rac1. Simon et al. 2000 [20], im-
plicated the effector domain of Rac1 in Stat3 binding by using effector
domain mutants of full-length Rac1, but the interaction was not
mapped to the NH2-terminal 54 amino acids of Rac1. In addition, we
have, for the ﬁrst time, identiﬁed the coiled-coil domain of Stat3 as
the domain that interacts with Rac1.
3.9. Expression of a Rac1 NH2-terminal peptide comprising Stat3-binding
residues suppresses Stat3 S727 phosphorylation following H/R
Since the 54 NH2-terminal residues of Rac1 are required for bind-
ing to Stat3, we expressed peptides representing residues 1–17
(Rac1–17) and 23–54 (Rac1–54) in 293 cells to inhibit this interaction
Fig. 5. (A,B) Knockdown of PKCζ with siRNA reduces S727 Stat3 phosphorylation in HUVECs during normoxia and following hypoxia–reoxygenation. (A) HUVECs were transfected
with control siRNA (si-control) or PKCζ siRNA (si-PKCζ), or with no siRNA (Control), lysed, and immunoblotted. (B) 48 h after transfection HUVECs were exposed to hypoxia for 2 h
and reoxygenation for 30 min, lysed, and immunoblotted. The experiment was done twice with similar results. (C,D) Following hypoxia–reoxygenation, PKCζ colocalizes with Stat3
in the cytoplasm, but after phosphorylation of S727, Stat3 is found in the nucleus without PKCζ. (C) HUVECs were exposed to hypoxia for 2 h and reoxygenation for 15 min. Cells
were ﬁxed and incubated with rabbit anti-Stat3 and goat anti-PKCζ antibodies with secondary anti-rabbit (red) and anti-goat (green) antibodies, and examined by confocal micros-
copy (63×). a) Stat3, b) PKCζ, c) nuclei (blue), d) merged image, and e) enlargement of cell in box to demonstrate cytoplasmic colocalization of Stat3 and PKCζ. (D) HUVECs under
normoxia or exposed to hypoxia for 2 h and reoxygenation for 60 min were ﬁxed and incubated with rabbit anti-p-S727 Stat3 and goat anti-PKCζ antibodies and detected by sec-
ondary antibodies (p-S727 Stat3, red; PKCζ, green), and examined by confocal microscopy (63×). H-R increases cytoplasmic and nuclear p-S727 Stat3, but there is no colocalization
with PKCζ. b) Merged image showing lack of colocalization, c) separated image of p-S727 Stat3, and d) separated image of PKCζ. The confocal microscopy experiments in C and D
were each performed twice with similar results.
Fig. 6. Stat3 and CA Rac1 colocalize following H/R. HUVECs were infected with adenoviruses as in Fig. 1, exposed to 2 h hypoxia and 5 min reoxygenation or a corresponding period
of normoxia, ﬁxed and processed for dual immunoﬂuorescent labeling with Stat3 (red) and Rac1 (green). Images of 5 nm thick sections were taken by confocal microscopy. Colo-
calization (yellow color in right panels) is seen predominantly on the cell membrane (arrow) and nuclear membrane (arrowhead), and inside the nucleus following H/R and in-
fection with Ad CA Rac1.
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Fig. 7. The amino acids that sustain Stat3 and Rac1 interaction reside within the coiled-
coil domain of Stat3 and the NH2-terminal 54 amino acids of Rac1. (A) CA Rac1 or
its segments and Stat3 were coexpressed in S. cerevisiae and assayed for expression
of reporter genes. (+) indicates reporter gene expression (interaction between the
proteins/peptides) and (−) indicates non-expression (no interaction). S-I, S-II and
S-III and the corresponding numbers represent position of molecular switches in the
Rac1 protein. (B) Stat3 or its different segments were coexpressed with CA Rac1 in
S. cerevisiae and assayed for expression of reporter genes as in (A). C-C = coiled-coil
domain, D-B = DNA-binding domain, L-D = linker domain, SH2 = src homology do-
main 2, and T-D = transactivation domain of Stat3.
1003S.N. Mattagajasingh et al. / Biochimica et Biophysica Acta 1823 (2012) 997–1006and determine the effect on Stat3 phosphorylation following H/R.
Cells transfected with Rac1–17 demonstrated decreased Stat3 S727
phosphorylation following H/R (pb0.001, Fig. 9A, lower panel). InFig. 8. Stat3 binds to Rac1 in vitro. (A) Puriﬁed GST-Rac1 fusion proteins are shown by Coom
or their segments was incubated with in vitro translated [35S]methionine-labeled Stat3α (B)
50–192. Similarly, Stat3 fragments 1–320 and 131–377 bound to GST/CA Rac1, but fragmencontrast, Rac1–54 had no signiﬁcant effect (Fig. 9A). Stat3 S727 phos-
phorylation was also inhibited when the Rac1–17 peptide was di-
rectly transfected into HUVECs exposed to hypoxia for 2 h and
reoxygenation for 15 or 30 min (pb0.01, pb0.05, respectively,
Fig. 9B, lower panel).
4. Discussion
Our results strongly support a central role of Rac1 in regulating the
activation of the JAK–Stat3 pathway in vascular endothelial cells fol-
lowing H/R. Phosphorylation of both Y705 and S727 residues of
Stat3 is clearly regulated by Rac1 in endothelial cells following H/R.
In addition, we have made several other new observations: 1) Stat3
associates with Rac1 and isoforms of PKC including PKCζ in a novel
multiprotein complex, providing a mechanism for H/R-induced
Stat3 S727 phosphorylation; 2) direct binding of Stat3 to Rac1 is me-
diated by the coiled-coil domain of Stat3 and the NH2-terminal 54
amino acids of Rac1, 3) transfection with a peptide comprising the
NH2-terminal 17 amino acid residues of Rac1 inhibits the phosphory-
lation of Stat3 S727 after H/R, and 4) Stat3 colocalizes with activated
Rac1 both at the cell membrane and inside the nucleus following H/R.
Thus, following H/R, Rac1 appears to control activation of Stat3 in en-
dothelial cells through multiple Rac-dependent pathways.
We found that Stat3 was associated with Rac1 in quiescent cells,
and that the association was increased following H/R, and even more
so with expression of CA Rac1 (Fig. 4). Consistent with these results,
we observed increased colocalization between Stat3 and Rac1 follow-
ing H/R (Fig. 6). Our data suggest that the NH2-terminal 54 amino
acids of Rac1, which include its GTP-binding and effector domains,
are necessary and sufﬁcient for direct binding to the coiled-coil do-
main of Stat3. These results are consistent with increased association
observed between Stat3 and CA Rac1 in IP and immunocolocalization
studies. The effector domain of Rac1 undergoes a conformational
change upon GTP binding, and CA Rac1 remains in a GTP bound
state. Since Rac1 is activated following H/R, it appears that theassie Blue staining. (B) Ten micrograms of GST alone or GST-fusion proteins of CA Rac1
, or its amino acid segments (C,D). All Rac1 fragments bound to Stat3 except for Rac1 aa
t 321–770 did not.
Fig. 9. Transfection of 293 or HUVECs with a Rac1 NH2-terminal peptide blocks Stat3 phosphorylation following H/R. (A) 293 cells were transfected with Rac1–17 (amino acids
1–17) or Rac1–54 (amino acids 23–54). Densitometry of the bands is based on 3 independent observations. H/R increased S727 Stat3 phosphorylation (p=0.05), and this was
inhibited by Rac1–17, but not Rac1–54. (B) HUVECs were transfected directly with Rac1–17 peptide. The upper right panel shows the results of transfection (IgG: red ﬂuorescent
dye localized in cytoplasm; FITC-labeled Rac1–17 peptide: green ﬂuorescence localized in nuclei and cytoplasm). The lower panel shows quantitation of 3 experiments. H/R in-
creased S727 Stat3 phosphorylation at 15 min and 30 min (p=0.014 and 0.035, respectively), and this increase was inhibited by Rac1–17.
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with other factors upon activation facilitate its association with
Stat3. Our ﬁnding is consistent with Simon et al [20], who reported
that Stat3 binding to Rac1 occurred only when Rac1 was in its activat-
ed (GTP-bound) form. The coiled-coil domain of Stat3 serves as an
adaptor domain for protein–protein interaction as it organizes in
four stranded helical coiled-coils, and has been reported to interact
with a number of proteins [43].
We constructed peptides comprising residues 1–17 and 23–54 of
the NH2-terminal end of Rac1 to inhibit its interaction with Stat3
and examine the resulting effect on Stat3 phosphorylation. We
found that peptide 1–17 did inhibit S727 phosphorylation following
H/R in HUVECs and 293 cells, while peptide 23–54 had no effect,
suggesting that it is the ﬁrst 17 amino acids of Rac1 that are involved
in Stat3 binding. This ﬁnding supports the hypothesis that physical in-
teraction between Rac1 and Stat3 is involved in Stat3 phosphorylation
in endothelial cells following H/R. Interestingly, the region from resi-
due 30–40 of Rac1 has been identiﬁed as an NH2-terminal effector
site that is required for binding to and activation of the p67phox subu-
nit of the NADPH oxidase [44], resulting in production of ROS. Since
peptide 1–17 was effective while peptide 23–54 was not, our results
suggest that the peptide inhibited Stat3 S727 phosphorylation by di-
rectly preventing Rac1–Stat3 interaction rather than by indirectly
inhibiting Rac1-mediated ROS production.
The correlation we observed between S727 phosphorylation and
association of Stat3 with PKC and Rac1 suggest that this association
may be, at least in part, a mechanism of Stat3 activation following
H/R (Fig. 4). We have, for the ﬁrst time, demonstrated that PKCζ, an
aPKC, is one of the isoforms of PKC that associates with Stat3 in anH/R dependent manner, and that knockdown of PKCζ by siRNA in-
hibits H/R-induced Stat3 S727 phosphorylation (Fig. 5B). However,
since Stat3 S727 phosphorylation was signiﬁcantly inhibited by Cal-
phostin C, which inhibits PKC by binding to the DAG-binding domain
[45] present only in cPKCs (isoforms α, βI/II and γ) and nPKCs (iso-
forms δ, ε, η(Λ), θ and μ), but absent in aPKCs (isoforms ζ, ι, and λ)
[46], our data suggest involvement of cPKC and/or nPKC isoforms in
addition to PKCζ. Other serine/threonine kinases, such as those in
the MAPK signaling pathways may also be involved in Stat3 S727
phosphorylation, as reported previously [45,47]. The contribution of
individual kinases will depend on their subcellular localization and
proximity to Stat3 and Rac1, and the extent of their activation upon
H/R.
Our results indicate a potential role of Rac1 in Stat3 activation in
the nucleus. Our observation of nuclear Stat3 in quiescent cells is con-
sistent with earlier reports that unphosphorylated Stat3 was constitu-
tively present in the nucleus and was engaged in regulation of gene
expression [48,49]. Although active Rac1 was prominently localized
at the cell membrane and inside the nucleus in normoxia, colocaliza-
tion with Stat3 was observed at the cell and nuclear membranes
only after H/R (Fig. 6). The ﬁnding of colocalization of Rac1 and Stat3
in the nucleus is consistent with the recent report of Simeone-
Penney et al demonstrating a similar ﬁnding during PDGF-activation
of human airway smooth muscle cells [21]. Transport of activated
Stat3 into the nucleus occurs as a complex with GTP-bound Rac1 and
MgcRacGAP (male germ cell RacGAP), which contains a nuclear local-
izing signal (NLS) [50].
Multiple isoforms of the NADPH oxidase are activated in discrete
subcellular compartments including membrane rufﬂes, caveolae, lipid
1005S.N. Mattagajasingh et al. / Biochimica et Biophysica Acta 1823 (2012) 997–1006rafts, endosomes and the nucleus [51]. A number of tyrosine and serine/
threonine kinases and PKC isoforms that are either constitutively nucle-
ar or that translocate to the nucleus, have also been reported [52]. PKCζ
has been shown to be constitutively nuclear, and activate MAPK path-
ways inside the nucleus during H/R [38]. Interestingly, we found PKCζ
to be mainly cytoplasmic. Following H/R, PKCζ physically associates
with Stat3 and colocalizeswith it in the cytoplasm.Once phosphorylated,
however, Stat3 appears to dissociate from PKCζ and travel to the nucleus
(Fig. 5C,D).
Stat3 has received recent attention for its cytoprotective effects
unrelated to gene transcription. Tyrosine 705-phosphorylated Stat3
has been shown to promote phosphorylation of survival proteins in
the Reperfusion Injury Salvage Kinase (RISK) pathway, including Akt,
ERK2, and GSK3β, in anoxic-reoxygenated chick hearts [53]. A pool of
Stat3 located in the mitochondria has been described with a direct,
non-transcriptional role in regulation of the electron transport chain
[54]. Overexpression of transcriptionally inactive Stat3 in mitochondria
attenuates damage to the mitochondria during cell stress, with de-
creased production of ROS and retention of cytochrome c [54]. Mito-
chondrial Stat3 appears to contribute to cytoprotection by stimulating
respiration and inhibiting mitochondrial permeability transition pore
opening [55]. Stat3 has also been shown to protect against postpartum
cardiomyopathy, although this may occur through transcriptional regu-
lation of ROS scavenging enzymes like manganese superoxide dismu-
tase [56].
Because of the pleiotropic effects of Rac1 in Stat3 activation, it has
been difﬁcult to elucidate the functional signiﬁcance of Rac1–Stat3
binding. Stat3may be recruited to kinase signaling complexes through
its association with Rac1, and the kinase(s) may then be activated in
physical proximity to Stat3 by factors such as Rac-effectors or Rac1-
mediated ROS. Alternatively, GTP-bound Rac1, by binding to Stat3,
might bring a conformational change in the Stat3molecule, or provide
coupling energy that favors binding of other factors such as protein ki-
nases to the Stat3 molecule. This combined activation by Rac1 GTPase
and protein kinases may be required for complete and highly speciﬁc
activation of Stat3 andmay be analogous to simultaneous activation of
WASP by GTP-bound Cdc42 and the tyrosine kinase, Lck [57]. Thus,
Rac1 and Stat3, in association with other factors, could establish
redox-active signaling platforms in different cellular compartments,
including the nucleus, that can serve as a sensor of cellular redox sta-
tus, and bring rapid alterations in cellular redox-responsive gene
expression.
A potential study limitation is the use of human umbilical vein
endothelial cells for most of our experiments. It is possible that our
resultswould have been different if we had used human arterial ormi-
crovascular endothelial cells, or endothelial cells from another species.
However, some of our experiments were also performed in COS-7 and
293 cells (of monkey and human embryonic kidney origin, respective-
ly), and yielded results similar to HUVECs (see Fig. 9), In addition, re-
sults consistent with our ﬁndings have been reported in a number of
other cell types, including human airway [21] and rat smooth muscle
cells [31].Funding
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